Bank of America’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,000
Closed -$1.19M 8103
2023
Q3
$1.19M Sell
6,000
-14,000
-70% -$3.53M ﹤0.01% 4687
2023
Q2
$6.49M Buy
20,000
+2,400
+14% +$686K ﹤0.01% 3144
2023
Q1
$4.12M Buy
+17,600
New +$4.45M ﹤0.01% 3704
2021
Q4
Sell
-14,900
Closed -$3.47M 8403
2021
Q3
$3.47M Buy
+14,900
New +$3.11M ﹤0.01% 3926
2020
Q1
Sell
-8,500
Closed -$631K 7027
2019
Q4
$631K Buy
+8,500
New +$546K ﹤0.01% 4844

Other funds holding INSP

Bank of America's INSP Position: Q1 2026 in Review

Bank of America reduced its Inspire Medical Systems (INSP) stake by 11% in Q1 2026, selling an estimated $1.68M and leaving 186,069 shares worth $9.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3002.

Bank of America first reported a position in INSP in Q2 2018 and has held it in 32 quarters since. The position peaked at $33M in Q2 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Bank of America held 186,069 shares of Inspire Medical Systems worth $9.6M as of Q1 2026.
  • Bank of America sold 24,057 Inspire Medical Systems shares in Q1 2026, an estimated $1.68M.
  • Inspire Medical Systems made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3002 holding.
  • Bank of America first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 32 quarters since.
  • Bank of America's Inspire Medical Systems position peaked at $33M in Q2 2025.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.